Literature DB >> 20075942

Granzyme B cleavage of autoantigens in autoimmunity.

E Darrah1, A Rosen.   

Abstract

The systemic autoimmune diseases are a complex group of disorders characterized by elaboration of high titer autoantibodies and immune-mediated damage of tissues. Two striking features of autoimmune rheumatic diseases are their self-sustaining nature and capacity for autoamplification, exemplified by disease flares. These features suggest the presence of a feed-forward cycle in disease propagation, in which immune effector pathways drive the generation/release of autoantigens, which in turn fuel the immune response. There is a growing awareness that structural modification during cytotoxic granule-induced cell death is a frequent and striking feature of autoantigens, and may be an important principle driving disease. This review focuses on granzyme B (GrB)-mediated cleavage of autoantigens including (i) features of GrB cleavage sites within autoantigens, (ii) co-location of cleavage sites with autoimmune epitopes, and (iii) GrB sensitivity of autoantigens in disease-relevant target tissue. The mechanisms whereby GrB-induced changes in autoantigen structure may contribute to the initiation and propagation of autoimmunity are reviewed and reveal that GrB has the potential to create or destroy autoimmune epitopes. As there remains no direct evidence showing a causal function for GrB cleavage of antigens in the generation of autoimmunity, this review highlights important outstanding questions about the function of GrB in autoantigen selection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20075942      PMCID: PMC3136751          DOI: 10.1038/cdd.2009.197

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  81 in total

Review 1.  Death by a thousand cuts: granzyme pathways of programmed cell death.

Authors:  Dipanjan Chowdhury; Judy Lieberman
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

2.  CD4 T-cell autoreactivity to the mitochondrial autoantigen PDC-E2 in AMA-negative primary biliary cirrhosis.

Authors:  Shinji Shimoda; Hiroshi Miyakawa; Minoru Nakamura; Hiromi Ishibashi; Kentaro Kikuchi; Hiroto Kita; Hiroaki Niiro; Youjirou Arinobu; Nobuyuki Ono; Ian R Mackay; M Eric Gershwin; Koichi Akashi
Journal:  J Autoimmun       Date:  2008-07-21       Impact factor: 7.094

3.  Granzyme B: evidence for a role in the origin of myasthenia gravis.

Authors:  L Casciola-Rosen; A Miagkov; K Nagaraju; F Askin; L Jacobson; A Rosen; D B Drachman
Journal:  J Neuroimmunol       Date:  2008-08-03       Impact factor: 3.478

Review 4.  Dominance and crypticity of T cell antigenic determinants.

Authors:  E E Sercarz; P V Lehmann; A Ametani; G Benichou; A Miller; K Moudgil
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

5.  Mapping of multiple B cell epitopes on the 70-kilodalton autoantigen of the U1 ribonucleoprotein complex.

Authors:  D S Cram; N Fisicaro; R L Coppel; S Whittingham; L C Harrison
Journal:  J Immunol       Date:  1990-07-15       Impact factor: 5.422

6.  T-cell epitopes on the 70-kDa protein of the (U1)RNP complex in autoimmune rheumatologic disorders.

Authors:  R M O'Brien; D S Cram; R L Coppel; L C Harrison
Journal:  J Autoimmun       Date:  1990-12       Impact factor: 7.094

7.  Human and mouse granzyme A induce a proinflammatory cytokine response.

Authors:  Sunil S Metkar; Cheikh Menaa; Julian Pardo; Baikun Wang; Reinhard Wallich; Marina Freudenberg; Stephen Kim; Srikumar M Raja; Lianfa Shi; Markus M Simon; Christopher J Froelich
Journal:  Immunity       Date:  2008-10-23       Impact factor: 31.745

8.  Antihemostatic activity of human granzyme B mediated by cleavage of von Willebrand factor.

Authors:  Marguerite S Buzza; Jennifer M Dyson; Hiuwan Choi; Elizabeth E Gardiner; Robert K Andrews; Dion Kaiserman; Christina A Mitchell; Michael C Berndt; Jing-Fei Dong; Phillip I Bird
Journal:  J Biol Chem       Date:  2008-06-24       Impact factor: 5.157

9.  Nucleolar antigens and autoantibodies in hepatocellular carcinoma and other malignancies.

Authors:  H Imai; R L Ochs; K Kiyosawa; S Furuta; R M Nakamura; E M Tan
Journal:  Am J Pathol       Date:  1992-04       Impact factor: 4.307

Review 10.  Pathogenic autoantibodies in systemic sclerosis.

Authors:  Armando Gabrielli; Silvia Svegliati; Gianluca Moroncini; Enrico V Avvedimento
Journal:  Curr Opin Immunol       Date:  2007-12       Impact factor: 7.486

View more
  29 in total

1.  General Approach for Tetramer-Based Identification of Autoantigen-Reactive B Cells: Characterization of La- and snRNP-Reactive B Cells in Autoimmune BXD2 Mice.

Authors:  Jennie A Hamilton; Jun Li; Qi Wu; PingAr Yang; Bao Luo; Hao Li; John E Bradley; Justin J Taylor; Troy D Randall; John D Mountz; Hui-Chen Hsu
Journal:  J Immunol       Date:  2015-04-17       Impact factor: 5.422

2.  Immunogenicity of autoantigens.

Authors:  Christina Backes; Nicole Ludwig; Petra Leidinger; Christian Harz; Jana Hoffmann; Andreas Keller; Eckart Meese; Hans-Peter Lenhof
Journal:  BMC Genomics       Date:  2011-07-04       Impact factor: 3.969

Review 3.  Autoantigens as Partners in Initiation and Propagation of Autoimmune Rheumatic Diseases.

Authors:  Antony Rosen; Livia Casciola-Rosen
Journal:  Annu Rev Immunol       Date:  2016-02-22       Impact factor: 28.527

4.  Proteolysis by Granzyme B Enhances Presentation of Autoantigenic Peptidylarginine Deiminase 4 Epitopes in Rheumatoid Arthritis.

Authors:  Erika Darrah; AeRyon Kim; Xi Zhang; Tatiana Boronina; Robert N Cole; Andrea Fava; Jon T Giles; Clifton O Bingham III; Michael J Chalmers; Patrick R Griffin; Scheherazade Sadegh-Nasseri; Antony Rosen
Journal:  J Proteome Res       Date:  2016-10-20       Impact factor: 4.466

5.  Identification of novel autoantigens by a triangulation approach.

Authors:  Tricia R Cottrell; John C Hall; Antony Rosen; Livia Casciola-Rosen
Journal:  J Immunol Methods       Date:  2012-08-11       Impact factor: 2.303

6.  IL-21-stimulated human plasmacytoid dendritic cells secrete granzyme B, which impairs their capacity to induce T-cell proliferation.

Authors:  Julien J Karrich; Loes C M Jachimowski; Maho Nagasawa; Angela Kamp; Melania Balzarolo; Monika C Wolkers; Christel H Uittenbogaart; S Marieke van Ham; Bianca Blom
Journal:  Blood       Date:  2013-02-13       Impact factor: 22.113

7.  NADPH oxidase inhibits the pathogenesis of systemic lupus erythematosus.

Authors:  Allison M Campbell; Michael Kashgarian; Mark J Shlomchik
Journal:  Sci Transl Med       Date:  2012-10-24       Impact factor: 17.956

8.  Granzyme B degrades extracellular matrix and contributes to delayed wound closure in apolipoprotein E knockout mice.

Authors:  P R Hiebert; D Wu; D J Granville
Journal:  Cell Death Differ       Date:  2013-08-02       Impact factor: 15.828

9.  Internally deleted human tRNA synthetase suggests evolutionary pressure for repurposing.

Authors:  Zhiwen Xu; Zhiyi Wei; Jie J Zhou; Fei Ye; Wing-Sze Lo; Feng Wang; Ching-Fun Lau; Jingjing Wu; Leslie A Nangle; Kyle P Chiang; Xiang-Lei Yang; Mingjie Zhang; Paul Schimmel
Journal:  Structure       Date:  2012-09-05       Impact factor: 5.006

10.  Development of autoantibodies against muscle-specific FHL1 in severe inflammatory myopathies.

Authors:  Inka Albrecht; Cecilia Wick; Åsa Hallgren; Anna Tjärnlund; Kanneboyina Nagaraju; Felipe Andrade; Kathryn Thompson; William Coley; Aditi Phadke; Lina-Marcela Diaz-Gallo; Matteo Bottai; Inger Nennesmo; Karine Chemin; Jessica Herrath; Karin Johansson; Anders Wikberg; A Jimmy Ytterberg; Roman A Zubarev; Olof Danielsson; Olga Krystufkova; Jiri Vencovsky; Nils Landegren; Marie Wahren-Herlenius; Leonid Padyukov; Olle Kämpe; Ingrid E Lundberg
Journal:  J Clin Invest       Date:  2015-11-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.